Recruiting studies: Influenza Human Covid 19

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Covid-19 and Influenza Oral Vaccine Study
Phase 1 · 1 location(s) · Vaxine Pty Ltd · NCT06355232 Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)
Phase N/A · 1 location(s) · VA Office of Research and Development · NCT06160128 Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT04794829 Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute
Phase 1/Phase 2 · 3 location(s) · PEACHES BIOTECH · NCT06684379 COVID-19 Coagulopathy Extension Study
Phase N/A · 1 location(s) · University of Iowa · NCT05334615 Nosocomial Respiratory Virus Infection
NA · 4 location(s) · Hospices Civils de Lyon · NCT06643039 Community Care Intervention to Decrease COVID-19 Vaccination Inequities
NA · 4 location(s) · RAND · NCT06156254 COMMUNITY - the COVID-19 Immunity Study
Phase N/A · 2 location(s) · Danderyd Hospital · NCT06784739 Dissecting Human Immune Responses to Infection With Influenza or SARS-CoV-2
Phase N/A · 1 location(s) · Washington University School of Medicine · NCT06848309 SURVEILLANCE, ASSESSMENT AND DETECTION OF INFLUENZA ASSOCIATED RESPIRATORY INFECTIONS IN HIV POSITIVE AND NEGATIVE INDIV
Phase N/A · 2 location(s) · Centre for Infectious Disease Research in Zambia · NCT07030075 BALance: ARDS Deconvolution by Bronchoalveolar Lavage Multiomics and Radiomics
Phase N/A · 1 location(s) · Medical University of Vienna · NCT07633366 A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults
Phase 1 · 12 location(s) · GlaxoSmithKline · NCT07464314 Clinical Study on the Immune Response Characteristics of Novel Coronavirus and Influenza Virus Infection
Phase N/A · 2 location(s) · Zhongnan Hospital · NCT06667063 Understanding Immunity to the Flu Vaccine in COVID-19 Patients
Phase N/A · 1 location(s) · Stanford University · NCT04579588 Respiratory Virus Sampling and Repository
Phase N/A · 2 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT05266222 Randomised Evaluation of COVID-19 Therapy
Phase 3 · 16 location(s) · University of Oxford · NCT04381936 A Multi-Site Clinical Evaluation of the LIAISON NES FLU A/B, RSV & COVID-19 Assay in Symptomatic Patients
NA · 3 location(s) · DiaSorin Molecular LLC · NCT06672692 Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
Phase 3 · 464 location(s) · AstraZeneca · NCT05624450 Influenza & COVID-19 Obstetric and Perinatal Epidemiology Study in India
Phase N/A · 2 location(s) · Boston University · NCT06168019 Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Phase 3 · 408 location(s) · UMC Utrecht · NCT02735707 COVID-19 Booster and IIV Schedule in Immunocompromised Hosts
Phase 2 · 3 location(s) · McGill University Health Centre/Research Institute of the Mc · NCT06599658 Dime La VerDAD: Verify, Debunk, and Disseminate
NA · 4 location(s) · University of Chicago · NCT06417762 Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection
Phase N/A · 1 location(s) · Consorci Sanitari de Terrassa · NCT04367883

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.